Masszi Andras, Di Ciano Caterina, Sirokmány Gábor, Arthur William T, Rotstein Ori D, Wang Jiaxu, McCulloch Christopher A G, Rosivall László, Mucsi István, Kapus András
Department of Surgery, The Toronto General Hospital, Toronto, Ontario M5G 1L7, Canada.
Am J Physiol Renal Physiol. 2003 May;284(5):F911-24. doi: 10.1152/ajprenal.00183.2002. Epub 2002 Dec 27.
New research suggests that, during tubulointerstitial fibrosis, alpha-smooth muscle actin (SMA)-expressing mesenchymal cells might derive from the tubular epithelium via epithelial-mesenchymal transition (EMT). Although transforming growth factor-beta(1) (TGF-beta(1)) plays a key role in EMT, the underlying cellular mechanisms are not well understood. Here we characterized TGF-beta(1)-induced EMT in LLC-PK(1) cells and examined the role of the small GTPase Rho and its effector, Rho kinase, (ROK) in the ensuing cytoskeletal remodeling and SMA expression. TGF-beta(1) treatment caused delocalization and downregulation of cell contact proteins (ZO-1, E-cadherin, beta-catenin), cytoskeleton reorganization (stress fiber assembly, myosin light chain phosphorylation), and robust SMA synthesis. TGF-beta(1) induced a biphasic Rho activation. Stress fiber assembly was prevented by the Rho-inhibiting C3 transferase and by dominant negative (DN) ROK. The SMA promoter was activated strongly by constitutively active Rho but not ROK. Accordingly, TGF-beta(1)-induced SMA promoter activation was potently abrogated by two Rho-inhibiting constructs, C3 transferase and p190RhoGAP, but not by DN-ROK. Truncation analysis showed that the first CC(A/T)richGG (CArG B) serum response factor-binding cis element is essential for the Rho responsiveness of the SMA promoter. Thus Rho plays a dual role in TGF-beta(1)-induced EMT of renal epithelial cells. It is indispensable both for cytoskeleton remodeling and for the activation of the SMA promoter. The cytoskeletal effects are mediated via the Rho/ROK pathway, whereas the transcriptional effects are partially ROK independent.
新研究表明,在肾小管间质纤维化过程中,表达α-平滑肌肌动蛋白(SMA)的间充质细胞可能通过上皮-间充质转化(EMT)源自肾小管上皮细胞。尽管转化生长因子-β1(TGF-β1)在EMT中起关键作用,但其潜在的细胞机制尚未完全明确。在此,我们对TGF-β1诱导的LLC-PK(1)细胞EMT进行了特征分析,并研究了小GTP酶Rho及其效应器Rho激酶(ROK)在随后的细胞骨架重塑和SMA表达中的作用。TGF-β1处理导致细胞接触蛋白(ZO-1、E-钙黏蛋白、β-连环蛋白)的错位和下调、细胞骨架重组(应力纤维组装、肌球蛋白轻链磷酸化)以及强烈的SMA合成。TGF-β1诱导Rho双相激活。Rho抑制性C3转移酶和显性负性(DN)ROK可阻止应力纤维组装。组成型活性Rho可强烈激活SMA启动子,但ROK不能。因此,两种Rho抑制构建体C3转移酶和p190RhoGAP可有效消除TGF-β1诱导的SMA启动子激活,而DN-ROK则不能。截短分析表明,第一个富含CC(A/T)的GG(CArG B)血清反应因子结合顺式元件对于SMA启动子的Rho反应性至关重要。因此,Rho在TGF-β1诱导的肾上皮细胞EMT中起双重作用。它对于细胞骨架重塑和SMA启动子的激活均不可或缺。细胞骨架效应通过Rho/ROK途径介导,而转录效应部分独立于ROK。